1 / 150

Thrombosis and embolism

Thrombosis and embolism . By Dr S Homathy. Thrombosis. Thrombosis is the formation of a solid mass (blood clot) from the constituents of blood Platelets Fibrin Entrapped red cells and white cells Within the heart or vascular system in a living organism.

amelie
Télécharger la présentation

Thrombosis and embolism

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Thrombosis and embolism By Dr S Homathy

  2. Thrombosis • Thrombosis is the formation of a solid mass (blood clot) from the constituents of blood • Platelets • Fibrin • Entrapped red cells and white cells • Within the heart or vascular system in a living organism

  3. The development of a clot is life-saving when a large vessel ruptures or is severed. • However, when a thrombus develops within the vascular system, it may be life-threatening

  4. Thrombosis is the consequence of inappropriate activation ( pathological) of the processes of normal haemostasis

  5. Normal Haemostasis • Maintain blood in a fluid, clot-free state in normal vessels • Also inducing the rapid formation of a localized haemostatic plug at the site of injury. • Both are influenced by • components of the blood vessel wall, • platelets • the clotting sequence.

  6. The integrity of the blood vessel wall is crucial in normal haemostasisas well as in thrombosis.

  7. Normal Haemostasis Vessel injury – • brief period of arteriolar vasoconstriction (neurogenic reflex ,endothelin) • Endothelial injury exposes ECM (highly thrombogenic material). • Platelets adhere to endothelial cells and ECM, and are activated.

  8. They release their secretary granules. • Platelet aggregation occurs forming haemostatic plug (Primary haemostasis) • Tissue factor (produced by endothelium) activates coagulation – • formation of thrombin which act on finbrinogen to form fibrin (secondary Haemostsis)

  9. The process continues to form the permanent plug formed by polymerized fibrin and platelet aggregates. • At the same time tissue plasminogen activator (t-PA) is formed and it limits haemostatic plug. • Fibrinolysis is also activated to limit haemostatic plug to the site of injury

  10. Normal Endothelium • Endothelial cells are activated by injury, infection, plasma mediators and cytokines. • They have pro-thrombotic and anti-thrombotic functions

  11. Endothelium • The endothelial cells serve to protect against thrombi formation by • Anti-thrombotic properties: • Anti-platelet effect: • Non activated platelets do not adhere to endothelium. • PGI2, and NO (produced by endothelium) prevent platelet adhesion • Anticoagulant properties: • Heparin-like molecule activate anti-thrombin III • Thrombomodulin binds thrombin which activate protein C (anticoagulant) • Fibrinolytic properties: • Endothelium synthesize t-PA (fibrinolysis

  12. Endothelial cells also have the procoagulant properties • Pro-thrombotic properties: • Von Willebrand factor: • It enhances binding of platelets to ECM. 2.Tissue factor • Produced by endothelium, it activates extrinsic clotting pathway • Plasminogen activator inhibitors (PAI)

  13. Platelets • Platelets are assigned a central role in normal haemostasisand thrombosis. • They adhere to sites of endothelial injury, • aggregate to form platelet masses,

  14. release granules rich in a variety of secretary products and synthesize several types of prostaglandins. • In normal haemostasis, platelets adhere to the severed margins of a vessel within seconds to a few minutes. • The most important stimulus to such adherence is the exposure of collagen fibrils

  15. Once adhered, platelets release two types of granules: (1) alpha granules which contain • fibrinogen, • beta thromboglobulin, • cationic protein • platelet factor 4 (a heparin neutralizing protein) (2) dense bodies, which are rich in • serotonin, • ADP, • ATP • ionized calcium

  16. Initially, the platelet aggregation forms a temporary haemostatic plug • which is friable and easily dislocated in rapidly flowing bloodstreams • at this time, the clotting sequence leads to the formation of thrombin • which is the most powerful platelet aggregator yet identified

  17. Platelets : (1) provide a temporary plug capable of controlling blood flow in small vessels in low pressure systems, (2) initiate the development of a permanent plug composed of aggregated platelets and fibrin, (3) release serotonin which augments vasoconstriction and (4) contributes to the coagulation mechanism.

  18. Coagulation system • The coagulation system plays a major role in normal haemostasis. • Maintenance of normal fluidity of blood involves the interplay between procoagulants and anticoagulants. • When the procoagulants dominate and clotting is triggered inappropriately in the intact cardiovascular system, • thrombi result.

  19. The critical events in blood clotting are the conversion of prothrombin to thrombin • the subsequent conversion of soluble fibrinogen into the stable fibrin polymer

  20. Thrombosis Thrombosis is influenced by three major factors: VIRCHOW’S TRIAD (1) injury to vascular endothelium, (2) alterations in normal blood flow and (3) alterations in the blood (hypercoagulability).

  21. Endothelial injury • Endothelial injury plays a dominant role in the formation of thrombi in arteries and in the heart. • Once the endothelium is damaged, subendothelial collagen may be exposed and • tissue thromboplastin, etc., is released and • the sequence of platelet adherence and activation of the clotting sequence follows

  22. Endothelial injury occurs in • myocardial infarction, • ulcerated atherosclerosis, • trauma, and • inflammatory disease of vessels. • Endothelial dysfunction is also a predisposing factor for thrombosis. Eg: • Hypertension, • bacterial endotoxins, • hypercholestrolemia, • radiation, • cigarette smoking.

  23. Blood Stasis and Turbulence of Flow Turbulence enhances endothelial injury. Stasis enhances venous thrombosis. • Both result in: • Bringing platelets close to endothelium • Accumulation of clotting factors • Prevent clotting factors inhibitors • Endothelial activation Eg: • aortic aneurysm, • MI, • valve stenosis, • rheumatic heart disease, • hyperviscosity, • sickle cell disease.

  24. Stasis and turbulence • Distrupt laminar flow • Prevent dilution of activated clotting factors by fresh flowing blood • Retard the inflow of clotting factor inhibitors and permits build – up of thrombi • Promote endothelial cell activation

  25. Hypercoagulability It is an alteration in coagulation leading to thrombosis. • Primary: (genetic) • Factor V mutation • Prothrombin mutation • Antithrombin III deficiency • Protein C or S deficiency

  26. Secondary:( acquired ) • High risk for thrombosis • Prolonged immobilization • Myocardial infarction • Tissue damage • Cancer • Prosthetic cardiac valves • DIC • Lupus anticoagulant • Low risk for thrombosis • AF • Cardiomyopathy • Sickle cell anaemia • Nephrotic syndrome • Contraceptive pills • Smoking

  27. Increased numbers of platelets, • increased platelet stickiness, • elevated levels of fibrinogen, • increased generation of thrombin, etc., • have been identified as causing hypercoagulability in various clinical conditions.

  28. Special categories among acquired causes 1.Heparin-induced Thrombocytopenia: ( HIT syndrom) • When heparin is administered it induces the formation of antibodies that bind platelets and activate them. • Occurs when unfractionated heparin is given. • Solution – give low-molecular Wt heparin • Have anticoagulant activity • Do not interact with platelets • Prolonged serum half life

  29. 2.Antiphospholipid syndrome (Lupus anticoagulant): • Antibodies to phospholipid (eg. Cardiolipin) • In-vitro: it inhibits coagulation( inhibit assembly of phospholipidcpx) • In-vivo: it induces coagulation • Approximately 20% of patients with a recent sroke were found to have anticardiolipin antibody

  30. Morphology • Thrombimay develop in the heart, arteries, veins and capillaries. • Arterial thrombi and cardiac thrombi occur at site of endothelial injury or turbulence of flow. • Venous thrombi occur in areas of blood stasis. • Thrombi usually are attached to the underlying vessel wall (mural thrombi)

  31. Arterial thrombi grow back(retrograde direction) to the heart. • Venous thrombi grow toward the heart.

  32. Arterial and cardiac thrombi are firmly attached to the wall Grossly and microscopically show • lines of Zahn (layers of fibrin and platelets alternate with layers of RBC and WBC. • Implies thrombosis at a site of blood flow • Venous thrombi do no show clear lamination. • Resemble coagulated blood( like clotted in test tube)

  33. Microscopic appearance of thrombi

  34. In the heart: • Attached to the underlying structure • Mural thrombi • common causes: • MI, • dilated cardiomyopathy, • arrhythmia, • myocarditis, • valvular disease.

  35. In arteries: • common causes: • atherosclerosis, • aneurysm. • Arterial thrombi usually occlude the lumen, • common in • coronary, • cerebral • femoral arteries.

  36. Deep Vein thrombosis (phlebothrombosis) • are almost always occlusive, • Red / stasis thrombi, • 90% occur in lower extremities. • Resemble postmortem clots • Firmer , almost always have a point of attachment • Transection reveal vague strands of pale gray fibrin

  37. Under special circumstances thrombi may form on heart vales. • Bacterial and fungal blood-born infection may lead to • valve damage • Development of large thrombotic masses/ vegetations ( infective endocarditis)

  38. Sterile vegetations can also develop on noninfected valves(NBTE) • Hypercoagulable states • Libman-sacks endocarditis • Occurs in SLE

  39. Classification of Thrombus according to • Color • Pale, formed of platelets and fibrin, • small, grayish white, firm and adherent • Red, formed of red cells and fibrin, • dark soft and loosely attached to the vessel • Mixed, common and has pale and red components • Presence or absence of bacteria • Infected or septic • Non infected or aseptic

  40. Sites of Thrombus Formation 1.Thrombus in veins: More common because of thin wall and slow blood flow: • Thrombophlebitis ----Septic • Phlebothrombosis---- occurs in the veins of the calf Ms and femoral ,iliac veins------ pulmonary emboli • In the varicose veins

  41. 2.Thrombosis in Arteries • less common than veins because of rapid flow and thick elastic wall but occur in arteries affected by: • Atheroma, polyarteritisnodosa and thromboangitisobliterans (roughness of the intima) • Aneurysm due to stasis • Lead to ischaemia

  42. 3.Thrombosis in the heart • more common in the the left side • Mural---- occur over infarction • Vegetations---- pale over the valve • Auricular--- adherent to valve, if detach called ball thrombus • Agonal--- red thrombi occurring in Rt. V at the time of death specially lobar pneumonia • Arterial and cardiac thrombosis possibly embolise to brain, kidneys, spleen

  43. Coronary artery thrombosis

  44. 4.Thrombosis in capillaries (very rare): • occur in acute inflammation ,sever cold and frost bite

  45. Fate of thrombus

  46. 1-septic thrombus • fragmented by the proteolytic enzymes into septic emboli causes pyaemic abscesses 2-Aseptic thrombus • its element disintegrate and form a pale red structure less mass If mass is small it dissolves by 1).fibrinolysis(dissolution) If mass is large it undergoes:

  47. 2.Propagation (progression) 3.Embolization 4.Organization and recanalization (inflammation and fibrosis)

  48. If mass is large it undergoes • Organization: • the thrombus is invaded by capillaries and fibroblast • change to fibrous mass • lead to permanent vascular occlusion • Organization and Canalization; • some time capillaries dilated and allow Passage of blood through the thrombus;

More Related